HNSBF OTC
Hansa Biopharma AB
1W: -11.1%
1M: -11.1%
3M: +13.4%
YTD: +13.1%
1Y: +9.7%
$3.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$549M
+18.6% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$549M
+18.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$296M
+190.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$548M | -$611M | -$832M | -$807M | -$529M |
| Depreciation & Amort. | $9M | $12M | $20M | $0 | $0 |
| Stock-Based Comp. | $57M | $58M | $61M | $0 | $0 |
| Change in Working Capital | $3M | $21M | $11M | -$64M | -$38M |
| Other Non-Cash Items | -$1M | $17M | -$16M | $196M | $18M |
| Operating Cash Flow | -$481M | -$503M | -$756M | -$675M | -$549M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$3M | -$284K | -$116K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $233M | $0 | $0 | $0 |
| Other Investing | $0 | $233M | $0 | $0 | $0 |
| Investing Cash Flow | -$2M | $229M | -$284K | -$116K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $728M | $0 | -$8M | -$10M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$5M | -$7M | -$8M | $0 | $10M |
| Financing Cash Flow | -$5M | $1.1B | -$8M | $347M | $848M |
| Net Change in Cash | -$488M | $845M | -$764M | -$327M | $296M |
| Cash End of Period | $651M | $1.5B | $732M | $405M | $701M |
| Free Cash Flow | -$484M | -$506M | -$756M | -$675M | -$549M |